NCT01764711View on ClinicalTrials.gov

Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Postural Tachycardia Syndrome
Interventions
DRUG

Cosyntropin administration

After 30 minutes of rest in the seated position, participants will be given cosyntropin intravenously. Blood samples will be taken 30 minutes pre-drug administration, 30 minutes post and 60 minutes post drug administration.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University

OTHER

NCT01764711 - Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS) | Biotech Hunter | Biotech Hunter